Free Cash Flow Build Up

Spero Therapeutics, Inc. (SPRO)

$1.97

-0.08 (-3.90%)
Year
A/P
Revenue
EBITDA
EBIT
Tax Rate
EBIAT
Depreciation
Accounts Receivable
Inventories
Accounts Payable
Capital Expenditure
UFCF
WACC
PV UFCF
SUM PV UFCF